Insufficient scRNA-seq data for expression of POU1F1 at single-cell level.
Insufficient scRNA-seq data for expression of POU1F1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 81% | 4.10 | 17 / 21 | 2% | 0.07 | 9 / 504 |
brain | 82% | 6.04 | 2170 / 2642 | 0% | 0.00 | 1 / 705 |
muscle | 78% | 4.67 | 626 / 803 | 0% | 0 | 0 / 0 |
prostate | 76% | 6.77 | 186 / 245 | 0% | 0.00 | 1 / 502 |
thymus | 73% | 4.33 | 474 / 653 | 0% | 0.00 | 1 / 605 |
intestine | 72% | 3.84 | 692 / 966 | 0% | 0.01 | 1 / 527 |
blood vessel | 70% | 3.51 | 936 / 1335 | 0% | 0 | 0 / 0 |
lung | 67% | 3.41 | 386 / 578 | 1% | 0.04 | 10 / 1155 |
kidney | 66% | 3.07 | 59 / 89 | 0% | 0.00 | 2 / 901 |
esophagus | 66% | 3.44 | 951 / 1445 | 1% | 0.01 | 1 / 183 |
spleen | 66% | 3.27 | 159 / 241 | 0% | 0 | 0 / 0 |
uterus | 64% | 2.79 | 109 / 170 | 2% | 0.05 | 7 / 459 |
stomach | 59% | 4.01 | 213 / 359 | 1% | 0.02 | 3 / 286 |
ovary | 59% | 2.21 | 107 / 180 | 0% | 0.00 | 1 / 430 |
adrenal gland | 58% | 9.76 | 150 / 258 | 0% | 0 | 0 / 230 |
liver | 54% | 2.62 | 122 / 226 | 0% | 0.01 | 1 / 406 |
breast | 53% | 3.02 | 242 / 459 | 0% | 0.01 | 3 / 1118 |
heart | 46% | 1.71 | 395 / 861 | 0% | 0 | 0 / 0 |
adipose | 44% | 2.30 | 526 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 43% | 1.50 | 140 / 328 | 1% | 0.01 | 1 / 178 |
peripheral blood | 30% | 1.04 | 281 / 929 | 0% | 0 | 0 / 0 |
skin | 29% | 2.22 | 522 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0021984 | Biological process | adenohypophysis development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0106222 | Molecular function | lncRNA binding |
Gene name | POU1F1 |
Protein name | POU domain protein POU class 1 homeobox 1 Pituitary-specific positive transcription factor 1 (PIT-1) (Growth hormone factor 1) (GHF-1) |
Synonyms | PIT1 GHF1 |
Description | FUNCTION: Transcription factor involved in the specification of the lactotrope, somatotrope, and thyrotrope phenotypes in the developing anterior pituitary. Specifically binds to the consensus sequence 5'-TAAAT-3'. Activates growth hormone and prolactin genes . . |
Accessions | ENST00000561167.5 ENST00000350375.7 [P28069-1] H0YK06 ENST00000344265.8 [P28069-2] P28069 H0YNM5 ENST00000560656.1 |